A long-acting flea and tick treatment from Merck Animal Health has earned approval for dogs at least six months old from the ...

The move bolsters Merck’s lineup as it braces for the 2028 loss of patent exclusivity for blockbuster cancer drug Keytruda.

Delaware state Rep. Sherae’a “Rae” Moore has lobbed a cease-and-desist letter to fellow Democrat and House Speaker Melissa Minor-Brown.

Merck, the New Jersey-based drug giant, is spending $1 billion on a new Delaware factory to bring production of its best-selling cancer drug Keytruda to the U.S. and speed future drugs to market.

(Reuters) -U.S. drugmaker Merck said on Tuesday it is investing $1 billion in a new Delaware plant to expand domestic production as it prepares to deal with President Donald Trump's tariffs.

In this analysis, we explore the potential upside for Merck despite its short-term hurdles.

After several weeks of work, the budget and one-time supplement bills pass the full Delaware House floor. Here's what to know.

Merck offers a 4.2% dividend yield but faces uncertainty with KEYTRUDA's LOE. Click here to find out why MRK stock is a Hold.

Merck's (NYSE:MRK) top-selling drug – Keytruda's – impressive recent growth tells a compelling story, but it's one with a predictable ending. The pharmaceutical giant's remarkable performance ...

Merck beats Q1 2025 estimates despite Gardasil sales drop, driven by Vaxneuvance, Winrevair & Welireg. Click here to find out why MRK stock is a Strong Buy.

Delaware Gov. Matt Meyer, a Democrat, signed a bill Tuesday legalizing physician-assisted suicide for certain terminally ill patients, arguing that the measure is about "compassion, dignity, and ...

Merck’s first-quarter net income increased as sales of its Keytruda cancer drug rose, but the Big Pharma company cut its 2025 adjusted earnings projection, partly to account for recently imposed ...